eFFECTOR Therapeutics Inc
OTC:EFTR
Income Statement
Earnings Waterfall
eFFECTOR Therapeutics Inc
Income Statement
eFFECTOR Therapeutics Inc
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue |
1
N/A
|
1
-11%
|
1
+23%
|
1
N/A
|
3
+92%
|
3
+16%
|
4
+11%
|
4
N/A
|
2
-57%
|
1
-56%
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||
| Operating Expenses |
(25)
|
(26)
|
(33)
|
(34)
|
(38)
|
(39)
|
(36)
|
(39)
|
(37)
|
(35)
|
(34)
|
(33)
|
|
| Selling, General & Administrative |
(5)
|
(8)
|
(13)
|
(16)
|
(17)
|
(16)
|
(13)
|
(12)
|
(12)
|
(11)
|
(11)
|
(11)
|
|
| Research & Development |
(20)
|
(18)
|
(20)
|
(19)
|
(21)
|
(23)
|
(23)
|
(27)
|
(25)
|
(23)
|
(23)
|
(22)
|
|
| Operating Income |
(24)
N/A
|
(25)
-6%
|
(32)
-27%
|
(33)
-3%
|
(36)
-9%
|
(36)
-2%
|
(32)
+10%
|
(35)
-9%
|
(35)
+0%
|
(34)
+4%
|
(34)
+0%
|
(33)
+3%
|
|
| Pre-Tax Income | |||||||||||||
| Interest Income Expense |
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Non-Reccuring Items |
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
18
|
50
|
60
|
61
|
44
|
12
|
1
|
0
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(26)
N/A
|
(9)
+64%
|
16
N/A
|
25
+61%
|
24
-5%
|
6
-77%
|
(23)
N/A
|
(36)
-58%
|
(37)
-4%
|
(36)
+3%
|
(36)
+0%
|
(35)
+3%
|
|
| Net Income | |||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(26)
|
(9)
|
16
|
25
|
24
|
6
|
(23)
|
(36)
|
(37)
|
(36)
|
(36)
|
(35)
|
|
| Net Income (Common) |
(40)
N/A
|
(23)
+42%
|
16
N/A
|
25
+61%
|
24
-5%
|
6
-77%
|
(23)
N/A
|
(36)
-58%
|
(37)
-4%
|
(36)
+3%
|
(36)
+0%
|
(35)
+3%
|
|
| EPS (Diluted) |
-24.37
N/A
|
-14.23
+42%
|
9.71
N/A
|
15.65
+61%
|
14.81
-5%
|
3.42
-77%
|
-13.76
N/A
|
-21.27
-55%
|
-19.44
+9%
|
-14.54
+25%
|
-16.37
-13%
|
-8.48
+48%
|
|